Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Mar 2026.
- Jitai Biological Technology has filed 1 Form D with the SEC, most recently Mar 2026 ( sold).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Jitai Biological Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jitai Biological Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jitai Biological Technology
Developer of biotechnology solutions designed to advance diagnostic and biomedical applications. The company engages in research, development, and commercialization of biological technologies, focusing on healthcare and life sciences markets, and aims to establish a competitive presence by delivering innovative diagnostic tools and biomedical products that meet growing global demand.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2025
- Ownership
- Privately Held (backing)
Jitai Biological Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jitai Biological Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jitai Biological Technology in its N-PORT filings yet. We sweep new filings monthly.